Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $375,280 - $412,500
2,000 New
2,000 $384,000
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $8.63 Million - $11.5 Million
63,800 New
63,800 $8.73 Million
Q1 2021

May 17, 2021

SELL
$137.51 - $190.8 $550,040 - $763,200
-4,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $658,520 - $847,720
4,000 New
4,000 $701,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.